Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne W Hancock

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Immunological Reviews|November 18, 2003
Chemokine receptor-dependent alloresponsesWayne W Hancock
The Lancet. Oncology|December 4, 2013
Effects of histone deacetylase inhibitors on alloresponsesWayne W Hancock
Transplantation|May 26, 2016
Isoform-Selective HDAC Inhibitor Therapy for Transplantation: Are We Ready for HDAC6?Wayne W Hancock
Journal of the American Society of Nephrology : JASN|February 22, 2002
Chemokines and transplant immunobiologyWayne W Hancock
Handbook of Experimental Pharmacology|September 1, 2011
Rationale for HDAC inhibitor therapy in autoimmunity and transplantationWayne W Hancock
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2007
Regulating regulatory T cells to achieve transplant toleranceRan Tao, Wayne W Hancock
Expert Opinion on Therapeutic Targets|July 11, 2018
How little is known about the role of human FOXP3+ Tregs in tumorsTatiana Akimova, Wayne W Hancock
Plos One|May 30, 2008
Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survivalRan Tao, Wayne W Hancock
Plos One|November 20, 2009
Three distinct domains contribute to nuclear transport of murine Foxp3Wayne W Hancock, Engin Ozkaynak
Current Opinion in Immunology|August 12, 2011
Immunogenetics and transplantationWayne W Hancock, Laurence A Turka
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Immunological Reviews|November 18, 2003
Chemokine receptor-dependent alloresponsesWayne W Hancock
The Lancet. Oncology|December 4, 2013
Effects of histone deacetylase inhibitors on alloresponsesWayne W Hancock
Transplantation|May 26, 2016
Isoform-Selective HDAC Inhibitor Therapy for Transplantation: Are We Ready for HDAC6?Wayne W Hancock
Journal of the American Society of Nephrology : JASN|February 22, 2002
Chemokines and transplant immunobiologyWayne W Hancock
Handbook of Experimental Pharmacology|September 1, 2011
Rationale for HDAC inhibitor therapy in autoimmunity and transplantationWayne W Hancock
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2007
Regulating regulatory T cells to achieve transplant toleranceRan Tao, Wayne W Hancock
Expert Opinion on Therapeutic Targets|July 11, 2018
How little is known about the role of human FOXP3+ Tregs in tumorsTatiana Akimova, Wayne W Hancock
Plos One|May 30, 2008
Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survivalRan Tao, Wayne W Hancock
Plos One|November 20, 2009
Three distinct domains contribute to nuclear transport of murine Foxp3Wayne W Hancock, Engin Ozkaynak
Current Opinion in Immunology|August 12, 2011
Immunogenetics and transplantationWayne W Hancock, Laurence A Turka
Pageof 18